The colon as a possible target for orally administered peptide and protein drugs

Susan Haupt, Abraham Rubinstein*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

87 Scopus citations

Abstract

Oral administration offers a potential portal to the superficial layers of the gastrointestinal (GI) tract (local delivery) and to the blood and lymphatics (systemic delivery). The harsh hydrolytic environment of the GI tract and the epithelial barriers to absorption, however, pose major challenges to the success of this mode of drug delivery for peptide and protein drugs. One approach to minimizing enzymatic degradation in the GI tract is to target drugs to the apparently less proteolytically active colon. In this review, the evidence supporting the colon as an attractive site for peptide and protein drug delivery will be discussed. The discussion will be confined to specific examples of delivery systems bearing both peptides and proteins that have been tested in the colonic context.

Original languageEnglish
Pages (from-to)499-551
Number of pages53
JournalCritical Reviews in Therapeutic Drug Carrier Systems
Volume19
Issue number6
DOIs
StatePublished - 2002

Keywords

  • Colonic diseases
  • Colonic drug carriers
  • Colonic proteolysis
  • Local treatment
  • Oral drug delivery

Fingerprint

Dive into the research topics of 'The colon as a possible target for orally administered peptide and protein drugs'. Together they form a unique fingerprint.

Cite this